Be very careful OK JMO
Checked it out. Looks good for a biopharma and it's not on the OTCBB yet. After that run up, I'll keep an eye on it. The ticker symbol is ABIO, by-the-way. Thanks for the tip.
There is a better choice than this phase 3 one
CRME has already Europe approved drug, cash value $0.50, stock at $0.44
Sentiment: Strong Buy